Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,599 GBX | -1.17% |
|
-0.34% | +10.26% |
Jun. 20 | GSK : Berenberg renews its buy recommendation | CF |
Jun. 19 | GSK : Deutsche Bank remains its Buy rating | ZD |
Sales 2024 * | 31.65B 40.02B | Sales 2025 * | 33.64B 42.54B | Capitalization | 65.21B 82.46B |
---|---|---|---|---|---|
Net income 2024 * | 5.54B 7B | Net income 2025 * | 6.5B 8.21B | EV / Sales 2024 * | 2.44 x |
Net Debt 2024 * | 12.13B 15.34B | Net Debt 2025 * | 8.64B 10.93B | EV / Sales 2025 * | 2.2 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
10
x | Employees | 70,212 |
Yield 2024 * |
3.8% | Yield 2025 * |
3.94% | Free-Float | 94.53% |
Latest transcript on GSK plc
1 day | -1.17% | ||
1 week | -0.34% | ||
Current month | -9.48% | ||
1 month | -8.94% | ||
3 months | -4.47% | ||
6 months | +10.28% | ||
Current year | +10.26% |
![Extreme 1575](/images/extremecours_fleche.png)
![Extreme 1575](/images/extremecours_fleche.png)
![Extreme 1453.2](/images/extremecours_fleche.png)
![Extreme 1302.6](/images/extremecours_fleche.png)
![Extreme 1280.92](/images/extremecours_fleche.png)
![Extreme 1280.92](/images/extremecours_fleche.png)
![Extreme 1280.92](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Hal Barron
BRD | Director/Board Member | 62 | 17-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.17% | 11 M€ | +0.83% | - | |
3.15% | 21 M€ | +9.61% | - | |
2.51% | 7 M€ | +9.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-21 | 1,599 | -1.17% | 16,605,890 |
24-06-20 | 1,618 | +0.09% | 3,916,051 |
24-06-19 | 1,616 | +0.28% | 3,034,402 |
24-06-18 | 1,612 | +0.75% | 4,665,533 |
24-06-17 | 1,600 | -0.28% | 3,788,234 |
Delayed Quote London S.E., June 21, 2024 at 11:35 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.26% | 82.33B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- GSK Stock